Findings

What do systematic reviews say?

107 questions · 109 findings · 12 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 23 · 21.1%GRADE not reported 5 · 4.6%Very low 19 · 17.4%Low 38 · 34.9%Moderate 22 · 20.2%High 2 · 1.8%

Positive pressure therapy vs placebo

Improvement in vertigo frequency · Ménière’s disease

Positive pressure therapy showed no clear difference in improvement in vertigo frequency compared with placebo (low certainty).

1 finding from 1 review

Positive pressure therapy for Ménière’s disease 2023 · Cochrane Headline outcomes only
RR 1.19 [0.82, 1.71]
1 study · 77 participants
Low

Positive pressure therapy vs placebo

Change in vertigo (global score) · Ménière’s disease

1 finding from 1 review

Positive pressure therapy for Ménière’s disease 2023 · Cochrane Headline outcomes only
no estimate extracted
1 study · 68 participants
Very low

Positive pressure therapy vs placebo

Change in vertigo frequency · Ménière’s disease

1 finding from 1 review

Positive pressure therapy for Ménière’s disease 2023 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 202 participants
Very low

Positive pressure therapy vs placebo

Serious adverse events · Ménière’s disease

The review found no eligible studies for this question.

1 finding from 1 review

Positive pressure therapy for Ménière’s disease 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Positive pressure therapy vs placebo

Proportion of days with vertigo in 4 weeks: vertigo scores > 2 · Ménière’s disease

1 finding from 1 review

Positive pressure therapy for Ménière's disease or syndrome 2015 · Cochrane Headline outcomes only
no estimate extracted
1 study · 62 participants
Moderate

Positive pressure therapy vs placebo

Cumulative vertigo scores after 4 months · Ménière’s disease

1 finding from 1 review

Positive pressure therapy for Ménière's disease or syndrome 2015 · Cochrane Headline outcomes only
no estimate extracted
1 study · 68 participants
Moderate

Positive pressure therapy vs placebo

Vertigo days in 4 months: vertigo scores > 2 · Ménière’s disease

1 finding from 1 review

Positive pressure therapy for Ménière's disease or syndrome 2015 · Cochrane Headline outcomes only
no estimate extracted
1 study · 68 participants
Moderate

Positive pressure therapy vs placebo

Vertigo (frequency) · Ménière’s disease

1 finding from 1 review

Positive pressure therapy for Ménière's disease or syndrome 2015 · Cochrane Headline outcomes only
no estimate extracted
1 study · 40 participants
Moderate

Positive pressure therapy vs placebo

VAS scores for vertigo after 8 weeks of treatment · Ménière’s disease

1 finding from 1 review

Positive pressure therapy for Ménière's disease or syndrome 2015 · Cochrane Headline outcomes only
no estimate extracted
1 study · 40 participants
Moderate

Positive pressure therapy vs placebo

Loss or gain of hearing in 4 months (dB) · Ménière’s disease

1 finding from 1 review

Positive pressure therapy for Ménière's disease or syndrome 2015 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 123 participants
Moderate

Positive pressure therapy vs placebo

Cumulative activity score · Ménière’s disease

1 finding from 1 review

Positive pressure therapy for Ménière's disease or syndrome 2015 · Cochrane Headline outcomes only
no estimate extracted
1 study · 68 participants
Moderate

Positive pressure therapy vs placebo

Change in functional profile in the 8 weeks before and after 4 weeks of treatment · Ménière’s disease

1 finding from 1 review

Positive pressure therapy for Ménière's disease or syndrome 2015 · Cochrane Headline outcomes only
no estimate extracted
1 study · 40 participants
Moderate

Positive pressure therapy vs placebo

Days of sick‐leave at 1 year · Ménière’s disease

1 finding from 1 review

Positive pressure therapy for Ménière's disease or syndrome 2015 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 125 participants
Moderate

Positive expiratory pressure plus routine treatment vs routine treatment alone

Duration of total antibiotic therapy ‐ not reported · people with pneumonia

The review found no eligible studies for this question.

1 finding from 1 review

Chest physiotherapy for pneumonia in adults 2022 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

NPPV vs oxygen therapy

Hospital mortality · adults (aged > 17 years) with acute respiratory failure after upper abdominal surgery

Noninvasive positive pressure ventilation (NPPV) showed no clear difference in hospital mortality compared with oxygen therapy (low certainty).

1 finding from 1 review

Noninvasive positive pressure ventilation for acute respiratory failure following upper abdominal surgery 2015 · Cochrane Headline outcomes only
RR 0.14 [0.01, 2.71]
1 study · 209 participants
Low

NPPV vs oxygen therapy

Rate of intubation · adults (aged > 17 years) with acute respiratory failure after upper abdominal surgery

Noninvasive positive pressure ventilation (NPPV) may leads to lower rate of tracheal Intubation compared with oxygen therapy (low certainty).

1 finding from 1 review

Noninvasive positive pressure ventilation for acute respiratory failure following upper abdominal surgery 2015 · Cochrane Headline outcomes only
RR 0.25 [0.08, 0.83]
2 studies · 269 participants
Low

NPPV vs oxygen therapy

Duration of ICU stay · adults (aged > 17 years) with acute respiratory failure after upper abdominal surgery

It is very uncertain whether noninvasive positive pressure ventilation (NPPV) changes ICU length of stay compared with oxygen therapy (very low certainty).

1 finding from 1 review

Noninvasive positive pressure ventilation for acute respiratory failure following upper abdominal surgery 2015 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 269 participants
Very low

Continuous positive airway pressure (CPAP) vs no CPAP

Erectile dysfunction · erectile dysfunction in men with obstructive sleep apnoea

2 findings from 1 review

Non‐invasive positive airway pressure therapy for improving erectile dysfunction in men with obstructive sleep apnoea 2021 · Cochrane Headline outcomes only
no estimate extracted
1 study · 27 participants
Very low
Non‐invasive positive airway pressure therapy for improving erectile dysfunction in men with obstructive sleep apnoea 2021 · Cochrane Headline outcomes only
no estimate extracted
1 study · 57 participants
Very low

Continuous positive airway pressure (CPAP) vs sham CPAP

Health‐related quality of life · erectile dysfunction in men with obstructive sleep apnoea

1 finding from 1 review

Non‐invasive positive airway pressure therapy for improving erectile dysfunction in men with obstructive sleep apnoea 2021 · Cochrane Headline outcomes only
no estimate extracted
1 study · 61 participants
GRADE not reported

Continuous positive airway pressure (CPAP) vs sham CPAP

Minor adverse events · erectile dysfunction in men with obstructive sleep apnoea

The review found no eligible studies for this question.

1 finding from 1 review

Non‐invasive positive airway pressure therapy for improving erectile dysfunction in men with obstructive sleep apnoea 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found